Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate

Hyperkalaemia is a life-threatening condition, resulting from decreased renal function or dysfunctional homoeostatic mechanisms, often affecting patients with cardiovascular (CV) disease. Drugs such as renin-angiotensin-aldosterone system inhibitors (RAASi) are known to improve outcomes in CV patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosano, Giuseppe M C, Spoletini, Ilaria, Agewall, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392412/
https://www.ncbi.nlm.nih.gov/pubmed/30837802
http://dx.doi.org/10.1093/eurheartj/suy035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392412/
https://www.ncbi.nlm.nih.gov/pubmed/30837802
http://dx.doi.org/10.1093/eurheartj/suy035

Ejemplares similares